Significant scientific, medical, and media attention has been given to incretin mimetics in the treatment of type 2 diabetes mellitus (T2DM) and obesity, as well as in numerous additional seemingly unrelated conditions—and rightfully so. Here, GCG is linked to obesity due to melanocortin 4 receptor deficiency.